4,873 Items Subject to Drug Re-Evaluation Reviews

The Korea Food and Drug Administration (KFDA) has released the list of pharmaceutical items subject to this year's re-evaluation reviews on 4,873 items from 4 therapeutic groups with 21 subcategories.

Of the total 4,873 items, the majority of them subject to the upcoming reviews is the tonic medicine group at 2,096 items from 8 therapeutic subcategories, followed by the vitamin group at 1,4...